OrthoPediatrics (KIDS) announced its partner, iotaMotion, has received FDA 510(k) clearance for expanded pediatric use of its iotaSOFT Insertion System. The system is now cleared for use in patients four years of age and older, extending access to robotic-assisted cochlear implantation for school-aged children. “This milestone allows us to leverage our existing capabilities and bring the same discipline, focus, and pediatric-first expertise beyond orthopedics. We are excited to extend our ability to help more children through improved clinical care and efficiency in the ENT space with an advanced technology like iotaSOFT,” commented David Bailey, President & CEO of OrthoPediatrics.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KIDS:
- OrthoPediatrics initiated with a Buy at TD Cowen
- OrthoPediatrics (KIDS): Pediatric Ortho Leader in an Underpenetrated Market with Improving Profitability and Valuation Upside
- OrthoPediatrics: Strengthening Fundamentals, Sustained Double-Digit Growth, and Improving Cash Generation Support Buy Rating
- OrthoPediatrics Highlights Growth Strategy in 2026 Investor Presentations
- OrthoPediatrics sees FY25 revenue $236.1M, consensus $233.99M